Advertisement

Loading...

Innovator IBD ETF Leaders ETF

LDRS•AMEX
Financial Services
Asset Management
$28.27
$-0.15(-0.53%)
U.S. Market is Open • 14:02

Innovator IBD ETF Leaders ETF (LDRS) Stock Overview

Explore Innovator IBD ETF Leaders ETF’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap8.2M
P/E RatioN/A
EPS (TTM)N/A
ROE0.00%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$28.61

LDRS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Innovator IBD ETF Leaders ETF (LDRS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $28.61.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 8.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
21.36%
5-Year Change
15.93%
All-Time (Max) Change
12.18%

Contact Information

NaN
800-208-5212
NaN, NaN, DE, NaN

Company Facts

IPO DateDec 20, 2017
CountryUS

Frequently Asked Questions